343 related articles for article (PubMed ID: 29801010)
1. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
[TBL] [Abstract][Full Text] [Related]
2. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
Roumpf SK; Hunter BR
Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
[No Abstract] [Full Text] [Related]
3. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
[TBL] [Abstract][Full Text] [Related]
4. Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials.
Nedel WL; Rech TH; Ribeiro RA; Pellegrini JAS; Moraes RB
Crit Care Med; 2019 Jan; 47(1):e44-e51. PubMed ID: 30303842
[TBL] [Abstract][Full Text] [Related]
5. Vasopressors for hypotensive shock.
Gamper G; Havel C; Arrich J; Losert H; Pace NL; Müllner M; Herkner H
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD003709. PubMed ID: 26878401
[TBL] [Abstract][Full Text] [Related]
6. Vasopressors for hypotensive shock.
Havel C; Arrich J; Losert H; Gamper G; Müllner M; Herkner H
Cochrane Database Syst Rev; 2011 May; (5):CD003709. PubMed ID: 21563137
[TBL] [Abstract][Full Text] [Related]
7. Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock.
Honarmand K; Um KJ; Belley-Côté EP; Alhazzani W; Farley C; Fernando SM; Fiest K; Grey D; Hajdini E; Herridge M; Hrymak C; Møller MH; Kanji S; Lamontagne F; Lauzier F; Mehta S; Paunovic B; Singal R; Tsang JL; Wynne C; Rochwerg B
Can J Anaesth; 2020 Mar; 67(3):369-376. PubMed ID: 31797234
[TBL] [Abstract][Full Text] [Related]
8. Vasopressors for shock.
Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
10. [Vasopressin in distributive shock : Brief summary of the guidelines of the Canadian Critical Care Society published in December 2019].
Bayerl S; Wöhrle T; Kilger E
Anaesthesist; 2020 Mar; 69(3):159-161. PubMed ID: 32055884
[TBL] [Abstract][Full Text] [Related]
11. Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
Belletti A; Musu M; Silvetti S; Saleh O; Pasin L; Monaco F; Hajjar LA; Fominskiy E; Finco G; Zangrillo A; Landoni G
PLoS One; 2015; 10(11):e0142605. PubMed ID: 26558621
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
14. The effect of early vasopressin use on patients with septic shock: A systematic review and meta-analysis.
Huang H; Wu C; Shen Q; Xu H; Fang Y; Mao W
Am J Emerg Med; 2021 Oct; 48():203-208. PubMed ID: 33975132
[TBL] [Abstract][Full Text] [Related]
15. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L; Wang P; Li C; Xie J
Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
[TBL] [Abstract][Full Text] [Related]
16. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
[TBL] [Abstract][Full Text] [Related]
17. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
18. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
Zhong L; Ji XW; Wang HL; Zhao GM; Zhou Q; Xie B
J Intensive Care; 2020 Oct; 8(1):83. PubMed ID: 33292658
[TBL] [Abstract][Full Text] [Related]
19. Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis.
Masarwa R; Paret G; Perlman A; Reif S; Raccah BH; Matok I
Crit Care; 2017 Jan; 21(1):1. PubMed ID: 28057037
[TBL] [Abstract][Full Text] [Related]
20. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
